SEARCH

SEARCH BY CITATION

References

  • Adlam C, Knights JM, Mugridge A, Williams JM & Lindon JC (1987) Production of colominic acid by Pasteurella haemolytica serotype A2 organisms. FEMS Microbiol Lett 42: 2325.
  • Al-haj Ali H, Sawada T, Hatakeyama H, Katayama Y, Ohtsuki N & Itoh O (2004a) Invasion of chicken embryo fibroblast cells by avian Pasteurella multocida. Vet Microbiol 104: 5562.
  • Al-haj Ali H, Sawada T, Hatakeyama H, Ohtsuki N & Itoh O (2004b) Characterization of a 39kDa capsular protein of avian Pasteurella multocida using monoclonal antibodies. Vet Microbiol 100: 4353.
  • Allison DD & Grande-Allen KJ (2006) Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng 12: 21312140.
  • Almeida RA & Oliver SP (1993) Antiphagocytic effect of the capsule of Streptococcus uberis. Zentralbl Veterinarmed B 40: 707714.
  • Almeida A, Albuquerque P, Araujo R, Ribeiro N & Tavares F (2013) Detection and discrimination of common bovine mastitis-causing streptococci. Vet Microbiol 164: 370377.
  • Andreishcheva EN & Vann WF (2006) Escherichia coli BL21(DE3) chromosome contains a group II capsular gene cluster. Gene 384: 113119.
  • Annunziato PW, Wright LF, Vann WF & Silver RP (1995) Nucleotide sequence and genetic analysis of the neuD and neuB genes in region 2 of the polysialic acid gene cluster of Escherichia coli K1. J Bacteriol 177: 312319.
  • Anzai T, Timoney JF, Kuwamoto Y, Fujita Y, Wada R & Inoue T (1999) In vivo pathogenicity and resistance to phagocytosis of Streptococcus equi strains with different levels of capsule expression. Vet Microbiol 67: 277286.
  • Ashbaugh CD, Moser TJ, Shearer MH, White GL, Kennedy RC & Wessels MR (2000) Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol 2: 283292.
  • Avci FY & Kasper DL (2010) How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol 28: 107130.
  • Azeredo J & Sutherland IW (2008) The use of phages for the removal of infectious biofilms. Curr Pharm Biotechnol 9: 261266.
  • Baker J, Dong S & Pritchard D (2002) The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochem J 365: 317322.
  • Barrett B, Ebah L & Roberts IS (2002) Genomic structure of capsular determinants. Curr Top Microbiol 264: 137155.
  • Barth S, Duncker S, Hempe J, Breves G, Baljer G & Bauerfeind R (2009) Escherichia coli Nissle 1917 for probiotic use in piglets: evidence for intestinal colonization. J Appl Microbiol 107: 16971710.
  • Bendaoud M, Vinogradov E, Balashova NV, Kadouri DE, Kachlany SC & Kaplan JB (2011) Broad-spectrum biofilm inhibition by Kingella kingae exopolysaccharide. J Bacteriol 193: 38793886.
  • Bitter-Suermann D, Goergen I & Frosch M (1986) Monoclonal antibodies to weak immunogenic Escherichia coli and meningococcal capsular polysaccharides. Protein-Carbohydrate Interactions in Biological Systems: The Molecular Biology of Microbial Pathogenicity (Lark DL, ed.), pp. 395396. Academic Press, London.
  • Blank LM, Hugenholtz P & Nielsen LK (2008) Evolution of the hyaluronic acid synthesis (has) operon in Streptococcus zooepidemicus and other pathogenic streptococci. J Mol Evol 67: 1322.
  • Bliss JM, Garon CF & Silver RP (1996) Polysialic acid export in Escherichia coli K1: the role of KpsT, the ATP-binding component of an ABC transporter, in chain translocation. Glycobiology 6: 445452.
  • Boeriu CG, Springer J, Kooy FK, van den Broek LAM & Eggink G (2013) Production methods for hyaluronan. Int J Carbohydr Chem 2013: 114.
  • Born J, Klaus J, Assmann KJ, Lindahl U & Berden JH (1996) N-Acetylated domains in heparan sulfates revealed by a monoclonal antibody against the Escherichia coli K5 capsular polysaccharide. Distribution of the cognate epitope in normal human kidney and transplant kidney with chronic vascular rejection. J Biol Chem 271: 2280222809.
  • Borrathybay E, Sawada T, Kataoka Y, Okiyama E, Kawamoto E & Amao H (2003a) Capsule thickness and amounts of a 39kDa capsular protein of avian Pasteurella multocida type A strains correlate with their pathogenicity for chickens. Vet Microbiol 97: 215227.
  • Borrathybay E, Sawada T, Kataoka Y, Ohtsu N, Takagi M, Nakamura S & Kawamoto E (2003b) A 39kDa protein mediates adhesion of avian Pasteurella multocida to chicken embryo fibroblast cells. Vet Microbiol 97: 229243.
  • Bortolussi R, Ferrieri P, Björkstén B & Quie PG (1979) Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis. Infect Immun 25: 293298.
  • Bøvre K, Bryn K, Closs O, Hagen N & Frøholm LO (1983) Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation. NIPH Ann 6: 6573.
  • Boyce JD, Chung JY & Adler B (2000a) Genetic organisation of the capsule biosynthetic locus of Pasteurella multocida M1404 (B:2). Vet Microbiol 72: 121134.
  • Boyce JD, Chung JY & Adler B (2000b) Pasteurella multocida capsule: composition, function and genetics. J Biotechnol 83: 153160.
  • Boyce JD, Harper M, Wilkie IW & Adler B (2010) Pasteurella. Pathogenesis of Bacterial Infections in Animals, 4th edn (Gyles CL, Prescott J, Songer G & Thoen CO, eds), pp. 325346. Wiley-Blackwell, DOI: 10.1002/9780470958209.ch17.
  • Bronner D, Sieberth V, Pazzani C, Smith A, Boulnois G, Roberts I, Jann B & Jann K (1993) Synthesis of the K5 (group II) capsular polysaccharide in transport-deficient recombinant Escherichia coli. FEMS Microbiol Lett 113: 279284.
  • Brooks HJ, O'Grady F, McSherry MA & Cattell WR (1980) Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection. J Med Microbiol 13: 5768.
  • Bushell SR, Mainprize IL, Wear MA, Lou H, Whitfield C & Naismith JH (2013) Wzi is an outer membrane lectin that underpins Group 1 capsule assembly in Escherichia coli. Structure 21: 844853.
  • Byarugaba DK, Minga UM, Gwakisa PS, Katunguka-Rwakishaya E, Bisgaard M & Olsen JE (2007) Virulence characterization of Avibacterium paragallinarum isolates from Uganda. Avian Pathol 36: 3542.
  • Calvinho LF, Almeida RA & Oliver SP (1998) Potential virulence factors of Streptococcus dysgalactiae associated with bovine mastitis. Vet Microbiol 61: 93110.
  • Capila I & Linhardt RJ (2002) Heparin-protein interactions. Angew Chem Int Edit 41: 391412.
  • Chang RCC, Chiu K, Ho YS & So KF (2009) Modulation of neuroimmune responses on glia in the central nervous system: implication in therapeutic intervention against neuroinflammation. Cell Mol Immunol 6: 317326.
  • Chang AL, Wolf JJ & Smolke CD (2012a) Synthetic RNA switches as a tool for temporal and spatial control over gene expression. Curr Opin Biotechnol 23: 679688.
  • Chang Y, Yang B, Zhao X & Linhardt RJ (2012b) Analysis of glycosaminoglycan-derived disaccharides by capillary electrophoresis using laser-induced fluorescence detection. Anal Biochem 427: 9198.
  • Chen X & Varki A (2010) Advances in the biology and chemistry of sialic acids. ACS Chem Biol 5: 163176.
  • Chen SL, Hung CS, Xu J et al. (2006) Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: a comparative genomics approach. P Natl Acad Sci USA 103: 59775982.
  • Chen WY, Marcellin E, Hung J & Nielsen LK (2009) Hyaluronan molecular weight is controlled by UDP-N-acetylglucosamine concentration in Streptococcus zooepidemicus. J Biol Chem 284: 1800718014.
  • Cho S, Lee BR, Cho BK, Kim JH & Kim BG (2013) In vitro selection of sialic acid specific RNA aptamer and its application to the rapid sensing of sialic acid modified sugars. Biotechnol Bioeng 110: 905913.
  • Chung JY, Zhang Y & Adler B (1998) The capsule biosynthetic locus of Pasteurella multocida A:1. FEMS Microbiol Lett 166: 289296.
  • Chung JY, Wilkie I, Boyce JD, Townsend KM, Frost AJ, Ghoddusi M & Adler B (2001) Role of capsule in the pathogenesis of fowl cholera caused by Pasteurella multocida serogroup A. Infect Immun 69: 24872492.
  • Cieslewicz M & Vimr E (1996) Thermoregulation of kpsF, the first region 1 gene in the kps locus for polysialic acid biosynthesis in Escherichia coli K1. J Bacteriol 178: 32123220.
  • Cimini D, De Rosa M & Schiraldi C (2012) Production of glucuronic acid-based polysaccharides by microbial fermentation for biomedical applications. Biotechnol J 7: 237250.
  • Cimini D, De Rosa M, Carlino E, Ruggiero A & Schiraldi C (2013) Homologous overexpression of rfaH in E. coli K4 improves the production of chondroitin-like capsular polysaccharide. Microb Cell Fact 12: 112.
  • Cobb BA, Wang Q, Tzianabos AO & Kasper DL (2004) Polysaccharide processing and presentation by the MHCII pathway. Cell 117: 677687.
  • Comstock LE & Kasper DL (2006) Bacterial glycans: key mediators of diverse host immune responses. Cell 126: 847850.
  • Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M & Marrie TJ (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41: 435464.
  • Crater DL & van de Rijn I (1995) Hyaluronic acid synthesis operon (has) expression in group A streptococci. J Biol Chem 270: 1845218458.
  • Cress BF, Linhardt RJ & Koffas MAG (2013a) Draft genome sequence of Escherichia coli strain Nissle 1917 (Serovar O6:K5:H1). Genome Announc 1: 12.
  • Cress BF, Greene ZR, Linhardt RJ & Koffas MAG (2013b) Draft genome sequence of Escherichia coli strain ATCC 23502 (Serovar O5:K4:H4). Genome Announc 1: 12.
  • Cress BF, Greene ZR, Linhardt RJ & Koffas MAG (2013c) Draft genome sequence of Escherichia coli strain ATCC 23506 (Serovar O10:K5:H4). Genome Announc 1: 12.
  • Cross AS (1990) The biologic significance of bacterial encapsulation. Curr Top Microbiol 150: 8795.
  • Crouch CF, LaFleur R, Ramage C, Reddick D, Murray J, Donachie W & Francis MJ (2012) Cross protection of a Mannheimia haemolytica A1 Lkt-/Pasteurella multocida ΔhyaE bovine respiratory disease vaccine against experimental challenge with Mannheimia haemolytica A6 in calves. Vaccine 30: 23202328.
  • Cunningham RK, Söderström TO, Gillman CF & Van Oss CJ (1975) Phagocytosis as a surface phenomenon. V. Contact angles and phagocytosis of rough and smooth strains of Salmonella typhimurium, and the influence of specific antiserum. Immunol Commun 4: 429442.
  • Cywes C & Wessels MR (2001) Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature 414: 648652.
  • Daines DA & Silver RP (2000) Evidence for multimerization of neu proteins involved in polysialic acid synthesis in Escherichia coli K1 using improved LexA-based vectors. J Bacteriol 182: 52675270.
  • Danino T, Mondragón-Palomino O, Tsimring L & Hasty J (2010) A synchronized quorum of genetic clocks. Nature 463: 326330.
  • Dasgupta S & Kasper DL (2010) Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. Adv Immunol 106: 6191.
  • Davies RL (2003) Characterization and comparison of Pasteurella multocida strains associated with porcine pneumonia and atrophic rhinitis. J Med Microbiol 52: 5967.
  • DeAngelis PL (1999) Hyaluronan synthases: fascinating glycosyltransferases from vertebrates, bacterial pathogens, and algal viruses. Cell Mol Life Sci 56: 670682.
  • DeAngelis PL (2002a) Evolution of glycosaminoglycans and their glycosyltransferases: Implications for the extracellular matrices of animals and the capsules of pathogenic bacteria. Anat Rec 268: 317326.
  • DeAngelis PL (2002b) Microbial glycosaminoglycan glycosyltransferases. Glycobiology 12: 9R16R.
  • DeAngelis PL (2012) Glycosaminoglycan polysaccharide biosynthesis and production: today and tomorrow. Appl Microbiol Biotechnol 94: 295305.
  • DeAngelis PL & Padgett-McCue AJ (2000) Identification and molecular cloning of a chondroitin synthase from Pasteurella multocida type F. J Biol Chem 275: 2412424129.
  • DeAngelis PL & White CL (2002) Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D. J Biol Chem 277: 72097213.
  • DeAngelis PL & White CL (2004) Identification of a distinct, cryptic heparosan synthase from Pasteurella multocida types A, D, and F. J Bacteriol 186: 85298532.
  • DeAngelis PL, Papaconstantinou J & Weigel PH (1993a) Isolation of a Streptococcus pyogenes gene locus that directs hyaluronan biosynthesis in acapsular mutants and in heterologous bacteria. J Biol Chem 268: 1456814571.
  • DeAngelis PL, Papaconstantinou J & Weigel PH (1993b) Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J Biol Chem 268: 1918119184.
  • DeAngelis PL, Jing W, Drake RR & Achyuthan AM (1998) Identification and molecular cloning of a unique hyaluronan synthase from Pasteurella multocida. J Biol Chem 273: 84548458.
  • DeAngelis PL, Gunay NS, Toida T, Mao W & Linhardt RJ (2002) Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively. Carbohydr Res 337: 15471552.
  • DeAngelis PL, Oatman LC & Gay DF (2003) Rapid chemoenzymatic synthesis of monodisperse hyaluronan oligosaccharides with immobilized enzyme reactors. J Biol Chem 278: 3519935203.
  • Deszo EL, Steenbergen SM, Freedberg DI & Vimr ER (2005) Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus. P Natl Acad Sci USA 102: 55645569.
  • Devi SJ, Schneerson R, Egan W, Vann WF, Robbins JB & Shiloach J (1991) Identity between polysaccharide antigens of Moraxella nonliquefaciens, group B Neisseria meningitidis, and Escherichia coli K1 (non-O acetylated). Infect Immun 59: 732736.
  • Donnio PY, Lerestif-Gautier AL & Avril JL (2004) Characterization of Pasteurella spp. strains isolated from human infections. J Comp Pathol 130: 137142.
  • Dougherty BA & van de Rijn I (1992) Molecular characterization of a locus required for hyaluronic acid capsule production in group A streptococci. J Exp Med 175: 12911299.
  • Durso LM, Bono JL & Keen JE (2005) Molecular serotyping of Escherichia coli O26:H11. Appl Environ Microbiol 71: 49414944.
  • Edwards U & Frosch M (1992) Sequence and functional analysis of the cloned Neisseria meningitidis CMP-NeuNAc synthetase. FEMS Microbiol Lett 75: 161166.
  • Edwards MS, Kasper DL, Jennings HJ, Baker CJ & Nicholson-Weller A (1982) Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol 128: 12781283.
  • Elowitz MB & Leibler S (2000) A synthetic oscillatory network of transcriptional regulators. Nature 403: 335338.
  • Engleberg NC, Heath A, Miller A, Rivera C & DiRita VJ (2001) Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 183: 10431054.
  • Erbel PJA, Barr K, Gao N, Gerwig GJ, Rick PD & Gardner KH (2003) Identification and biosynthesis of cyclic enterobacterial common antigen in Escherichia coli. J Bacteriol 185: 19952004.
  • Esko JD (1999) Proteoglycans and glycosaminoglycans. Essentials of Glycobiology (Varki A, Cummings R, Esko J, Freeze H, Hart G & Marth J, eds). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • Esko JD, Doering TL & Raetz CR (2009) Eubacteria and Archaea. Essentials of Glycobiology, 2nd edn (Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW & Etzler ME, eds). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
  • Ewers C, Lübke-Becker A, Bethe A, Kiebling S, Filter M & Wieler LH (2006) Virulence genotype of Pasteurella multocida strains isolated from different hosts with various disease status. Vet Microbiol 114: 304317.
  • Fillit HM, McCarty M & Blake M (1986) Induction of antibodies to hyaluronic acid by immunization of rabbits with encapsulated Streptococci. J Exp Med 164: 762776.
  • Finke A, Bronner D, Nikolaev AV, Jann B & Jann K (1991) Biosynthesis of the Escherichia coli K5 polysaccharide, a representative of group II capsular polysaccharides: polymerization in vitro and characterization of the product. J Bacteriol 173: 40884094.
  • Finne J (1982) Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain. J Biol Chem 257: 1196611970.
  • Finne J, Leinonen M & Mäkelä PH (1983) Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2: 355357.
  • Fregolino E, Ivanova R, Lanzetta R, Molinaro A, Parrilli M, Paunova-Krasteva T, Stoitsova SR & De Castro C (2012) Occurrence and structure of cyclic enterobacterial common antigen in Escherichia coli O157:H. Carbohydr Res 363: 2932.
  • Frosch M & Müller A (1993) Phospholipid substitution of capsular polysaccharides and mechanisms of capsule formation in Neisseria meningitidis. Mol Microbiol 8: 483493.
  • Frosch M, Görgen I, Boulnois GJ, Timmis KN & Bitter-Suermann D (1985) NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. P Natl Acad Sci USA 82: 11941198.
  • Frosch M, Edwards U, Bousset K, Krausse B & Weisgerber C (1991) Evidence for a common molecular origin of the capsule gene loci in gram-negative bacteria expressing group II capsular polysaccharides. Mol Microbiol 5: 12511263.
  • Gagneux P & Varki A (1999) Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology 9: 747755.
  • Gallagher JT (1989) The extended family of proteoglycans: social residents of the pericellular zone. Curr Opin Cell Biol 1: 12011218.
  • Ganguli S, Zapata G, Wallis T, Reid C, Boulnois G, Vann WF & Roberts IS (1994) Molecular cloning and analysis of genes for sialic acid synthesis in Neisseria meningitidis group B and purification of the meningococcal CMP-NeuNAc synthetase enzyme. J Bacteriol 176: 45834589.
  • Glode MP, Robbins JB, Liu TY, Gotschlich EC, Orskov I & Orskov F (1977) Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92. J Infect Dis 135: 94104.
  • Goller CC & Seed PC (2010) High-throughput identification of chemical inhibitors of E. coli Group 2 capsule biogenesis as anti-virulence agents. PLoS ONE 5: e11642.
  • Granoff DM, Bartoloni A, Ricci S et al. (1998) Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J Immunol 160: 50285036.
  • Hafez M, Hayes K, Goldrick M, Warhurst G, Grencis R & Roberts IS (2009) The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction. Infect Immun 77: 29953003.
  • Hammerschmidt S, Birkholz C, Zähringer U, Robertson BD, van Putten J, Ebeling O & Frosch M (1994) Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol 11: 885896.
  • Hancock V, Vejborg RM & Klemm P (2010) Functional genomics of probiotic Escherichia coli Nissle 1917 and 83972, and UPEC strain CFT073: comparison of transcriptomes, growth and biofilm formation. Mol Genet Genomics 284: 437454.
  • Hänfling P, Shashkov AS, Jann B & Jann K (1996) Analysis of the enzymatic cleavage (beta elimination) of the capsular K5 polysaccharide of Escherichia coli by the K5-specific coliphage: reexamination. J Bacteriol 178: 47474750.
  • Hanson BR & Neely MN (2012) Coordinate regulation of Gram-positive cell surface components. Curr Opin Microbiol 15: 204210.
  • Hanson LA, Ahlstedt S, Fasth A, Jodal U, Kaijser B, Larsson P, Lindberg U, Olling S, Sohl-Åkerlund A & Svanborg-Edén C (1977) Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections. J Infect Dis 136(Suppl): S144S149.
  • Harber MJ, Topley N & Asscher AW (1986) Virulence factors of urinary pathogens. Clin Sci 70: 531538.
  • Harrison OB, Claus H, Jiang Y et al. (2013) Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis 19: 566573.
  • Hashikawa S, Iinuma Y, Furushita M, Ohkura T, Nada T, Torii K, Hasegawa T & Ohta M (2004) Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 42: 186192.
  • Heidelberger M & Avery OT (1923) The soluble specific substance of pneumococcus. J Exp Med 38: 7379.
  • Hérias MV, Midtvedt T, Hanson LA & Wold AE (1997) Escherichia coli K5 capsule expression enhances colonization of the large intestine in the gnotobiotic rat. Infect Immun 65: 531536.
  • Hickey AM, Bhaskar U, Linhardt RJ & Dordick JS (2013) Effect of eliminase gene (elmA) deletion on heparosan production and shedding in Escherichia coli K5. J Biotechnol 165: 175177.
  • Hobb RI, Tzeng YL, Choudhury BP, Carlson RW & Stephens DS (2010) Requirement of NMB0065 for connecting assembly and export of sialic acid capsular polysaccharides in Neisseria meningitidis. Microbes Infect 12: 476487.
  • Hodson N, Griffiths G, Cook N, Pourhossein M, Gottfridson E, Lind T, Lidholt K & Roberts IS (2000) Identification that KfiA, a protein essential for the biosynthesis of the Escherichia coli K5 capsular polysaccharide, is an alpha-UDP-GlcNAc glycosyltransferase. The formation of a membrane-associated K5 biosynthetic complex requires KfiA, KfiB, and KfiC. J Biol Chem 275: 2731127315.
  • Höök M, Kjellén L & Johansson S (1984) Cell-surface glycosaminoglycans. Annu Rev Biochem 53: 847869.
  • Horwitz MA & Silverstein SC (1980) Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J Clin Invest 65: 8294.
  • Huskisson E (2008) Glucosamine and Chondroitin for Osteoarthritis. J Int Med Res 36: 11611179.
  • Jacques M, Kobisch M, Bélanger M & Dugal F (1993) Virulence of capsulated and noncapsulated isolates of Pasteurella multocida and their adherence to porcine respiratory tract cells and mucus. Infect Immun 61: 47854792.
  • Jann K & Jann B (1987) Polysaccharide antigens of Escherichia coli. Rev Infect Dis 9(Suppl 5): S517S526.
  • Jann B & Jann K (1990) Structure and biosynthesis of the capsular antigens of Escherichia coli. Curr Top Microbiol 150: 1942.
  • Jann K & Jann B (1997) Capsules of Escherichia coli. Escherichia Coli: Mechanisms of Virulence (Sussman M, ed.), pp. 113143. Cambridge University Press, Cambridge, UK.
  • Jann K & Jann B (1998) Bacterial polysaccharides related to mammalian structures. Polysaccharides: Structural Diversity and Functional Versatility (Dumitriu S, ed.), pp. 211236. Marcel Dekker, New York, NY.
  • Jarvis GA & Vedros NA (1987) Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect Immun 55: 174180.
  • Jelakovic S, Jann K & Schulz GE (1996) The three-dimensional structure of capsule-specific CMP: 2-keto-3-deoxy-manno-octonic acid synthetase from Escherichia coli. FEBS Lett 391: 157161.
  • Jennings HJ, Roy R & Michon F (1985) Determinant specificities of the groups B and C polysaccharides of Neisseria meningitidis. J Immunol 134: 26512657.
  • Jensen A & Kilian M (2012) Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes. J Clin Microbiol 50: 113126.
  • Jiang P, Li J, Han F, Duan G, Lu X, Gu Y & Yu W (2011) Antibiofilm activity of an exopolysaccharide from marine bacterium Vibrio sp. QY101. PLoS ONE 6: e18514.
  • Jing W & DeAngelis PL (2000) Dissection of the two transferase activities of the Pasteurella multocida hyaluronan synthase: two active sites exist in one polypeptide. Glycobiology 10: 883889.
  • Johnson JR (1991) Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 4: 80128.
  • Kabat EA, Nickerson KG, Liao J, Grossbard L, Osserman EF, Glickman E, Chess L, Robbins JB, Schneerson R & Yang YH (1986) A human monoclonal macroglobulin with specificity for alpha(2—8)-linked poly-N-acetyl neuraminic acid, the capsular polysaccharide of group B meningococci and Escherichia coli K1, which crossreacts with polynucleotides and with denatured DNA. J Exp Med 164: 642654.
  • Kaijser B (1973) Immunology of Escherichia coli: K antigen and its relation to urinary-tract infection. J Infect Dis 127: 670677.
  • Kaijser B & Jodal U (1984) Escherichia coli K5 antigen in relation to various infections and in healthy individuals. J Clin Microbiol 19: 264266.
  • Kaijser B, Hanson LA, Jodal U, Lidin-Janson G & Robbins JB (1977) Frequency of E. coli K antigens in urinary-tract infections in children. Lancet 1: 663666.
  • Kamhi E, Joo EJ, Dordick JS & Linhardt RJ (2013) Glycosaminoglycans in infectious disease. Biol Rev Camb Philos 88: 928943.
  • Kane TA, White CL & DeAngelis PL (2006) Functional characterization of PmHS1, a Pasteurella multocida heparosan synthase. J Biol Chem 281: 3319233197.
  • Kaper JB, Nataro JP & Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2: 123140.
  • Khalil AS & Collins JJ (2010) Synthetic biology: applications come of age. Nat Rev Genet 11: 367379.
  • Kim KJ, Elliott SJ, Di Cello F, Stins MF & Kim KS (2003) The K1 capsule modulates trafficking of E. coli-containing vacuoles and enhances intracellular bacterial survival in human brain microvascular endothelial cells. Cell Microbiol 5: 245252.
  • Kim PJ, Lee DY, Kim TY, Lee KH, Jeong H, Lee SY & Park S (2007) Metabolite essentiality elucidates robustness of Escherichia coli metabolism. P Natl Acad Sci USA 104: 1363813642.
  • Kim Y, Oh S & Kim SH (2009) Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem Biophys Res Commun 379: 324329.
  • Kim HU, Kim SY, Jeong H, Kim TY, Kim JJ, Choy HE, Yi KY, Rhee JH & Lee SY (2011) Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery. Mol Syst Biol 7: 115.
  • King MR, Steenbergen SM & Vimr ER (2007) Going for baroque at the Escherichia coli K1 cell surface. Trends Microbiol 15: 196202.
  • Klainer AS & Geis I (1975) Agents of Bacterial Disease. Medical Department, Harper & Row, New York, NY.
  • Köndgen S, Leider M, Lankester F, Bethe A, Lübke-Becker A, Leendertz FH & Ewers C (2011) Pasteurella multocida involved in respiratory disease of wild chimpanzees. PLoS ONE 6: e24236.
  • Kong F, Wang W, Tao J, Wang L, Wang Q, Sabananthan A & Gilbert GL (2005) A molecular-capsular-type prediction system for 90 Streptococcus pneumoniae serotypes using partial cpsA-cpsB sequencing and wzy- or wzx-specific PCR. J Med Microbiol 54: 351356.
  • Kong L, Harrington L, Li Q, Cheley S, Davis BG & Bayley H (2013) Single-molecule interrogation of a bacterial sugar transporter allows the discovery of an extracellular inhibitor. Nat Chem 5: 651659.
  • Korhonen TK, Valtonen MV, Parkkinen J, Väisänen-Rhen V, Finne J, Orskov F, Orskov I, Svenson SB & Mäkelä PH (1985) Serotypes, hemolysin production, and receptor recognition of Escherichia coli strains associated with neonatal sepsis and meningitis. Infect Immun 48: 486491.
  • Krahulec J, Krahulcová J, Medová M & Velebny V (2005) Influence of KfoG on capsular polysaccharide structure in Escherichia coli K4 strain. Mol Biotechnol 30: 129134.
  • Kröncke KD, Orskov I, Orskov F, Jann B & Jann K (1990) Electron microscopic study of coexpression of adhesive protein capsules and polysaccharide capsules in Escherichia coli. Infect Immun 58: 27102714.
  • Kuberan B & Linhardt R (2000) Carbohydrate based vaccines. Curr Org Chem 4: 653677.
  • Kumari K & Weigel PH (1997) Molecular cloning, expression, and characterization of the authentic hyaluronan synthase from group C Streptococcus equisimilis. J Biol Chem 272: 3253932546.
  • Lambert-Zechovsky N, Bingen E, Denamur E, Brahimi N, Brun P, Mathieu H & Elion J (1992) Molecular analysis provides evidence for the endogenous origin of bacteremia and meningitis due to Enterobacter cloacae in an infant. Clin Infect Dis 15: 3032.
  • Lamppa JW, Ackerman ME, Lai JI, Scanlon TC & Griswold KE (2011) Genetically engineered alginate lyase-PEG conjugates exhibit enhanced catalytic function and reduced immunoreactivity. PLoS ONE 6: e17042.
  • Lancefield RC (1933) A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 57: 571595.
  • Larue K, Ford RC, Willis LM & Whitfield C (2011) Functional and structural characterization of polysaccharide co-polymerase proteins required for polymer export in ATP-binding cassette transporter-dependent capsule biosynthesis pathways. J Biol Chem 286: 1665816668.
  • Laurent TC & Fraser JR (1992) Hyaluronan. FASEB J 6: 23972404.
  • Lebeer S, Vanderleyden J & De Keersmaecker SCJ (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8: 171184.
  • Lee CJ, Banks SD & Li JP (1991) Virulence, immunity, and vaccine related to Streptococcus pneumoniae. Crit Rev Microbiol 18: 89114.
  • Legoux R, Lelong P, Jourde C et al. (1996) N-acetyl-heparosan lyase of Escherichia coli K5: gene cloning and expression. J Bacteriol 178: 72607264.
  • Leying H, Suerbaum S, Kroll HP, Stahl D & Opferkuch W (1990) The capsular polysaccharide is a major determinant of serum resistance in K-1-positive blood culture isolates of Escherichia coli. Infect Immun 58: 222227.
  • Li L, Ly M & Linhardt RJ (2012) Proteoglycan sequence. Mol BioSyst 8: 16131625.
  • Li Y, Hai Y, Thon V, Chen Y, Muthana MM, Qu J, Hie L & Chen X (2013) Donor substrate promiscuity of the N-acetylglucosaminyltransferase activities of Pasteurella multocida heparosan synthase 2 (PmHS2) and Escherichia coli K5 KfiA. Appl Microbiol Biotechnol 2: 18.
  • Lidholt K & Fjelstad M (1997) Biosynthesis of the Escherichia coli K4 capsule polysaccharide. A parallel system for studies of glycosyltransferases in chondroitin formation. J Biol Chem 272: 26822687.
  • Lifely MR, Nowicka UT & Moreno C (1986) Analysis of the chain length of oligomers and polymers of sialic acid isolated from Neisseria meningitidis group B and C and Escherichia coli K1 and K92. Carbohydr Res 156: 123135.
  • Linhardt RJ & Toida T (2004) Role of glycosaminoglycans in cellular communication. Acc Chem Res 37: 431438.
  • Linhardt RJ, Galliher PM & Cooney CL (1986) Polysaccharide lyases. Appl Biochem Biotechnol 12: 135176.
  • Liu R, Xu Y, Chen M, Weïwer M, Zhou X, Bridges AS, DeAngelis PL, Zhang Q, Linhardt RJ & Liu J (2010) Chemoenzymatic design of heparan sulfate oligosaccharides. J Biol Chem 285: 3424034249.
  • Liu L, Liu Y, Li J, Du G & Chen J (2011) Microbial production of hyaluronic acid: current state, challenges, and perspectives. Microb Cell Fact 10: 19.
  • Lodinová-Žaadniková R, Tlaskalová-Hogenová H & Sonnenborn U (1992) Local and serum antibody response in full–term and premature infants after artificial colonization of the intestine with E. coli strain Nissle 1917 (Mutaflor®). Pediatr Allergy Immunol 3: 4348.
  • Loos M (1985) The complement system: activation and control. Curr Top Microbiol 121: 718.
  • Lu TK & Collins JJ (2007) Dispersing biofilms with engineered enzymatic bacteriophage. P Natl Acad Sci USA 104: 1119711202.
  • Lu S, Zhang X, Zhu Y, Kim KS, Yang J & Jin Q (2011) Complete genome sequence of the neonatal-meningitis-associated Escherichia coli strain CE10. J Bacteriol 193: 7005.
  • Luong TT & Lee CY (2002) Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence. Infect Immun 70: 33893395.
  • Ly M, Wang Z, Laremore TN, Zhang F, Zhong W, Pu D, Zagorevski DV, Dordick JS & Linhardt RJ (2011) Analysis of E. coli K5 capsular polysaccharide heparosan. Anal Bioanal Chem 399: 737745.
  • Marco ML, Pavan S & Kleerebezem M (2006) Towards understanding molecular modes of probiotic action. Curr Opin Biotechnol 17: 204210.
  • Martens EC, Roth R, Heuser JE & Gordon JI (2009) Cover image. J Biol Chem 284(27): cover.
  • Masson L, Holbein BE & Ashton FE (1982) Virulence linked to polysaccharide production in serogroup B Neisseria meningitidis. FEMS Microbiol Lett 13: 187190.
  • Mazmanian SK & Kasper DL (2006) The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 6: 849858.
  • Meredith TC & Woodard RW (2006) Characterization of Escherichia coli D-arabinose 5-phosphate isomerase encoded by kpsF: implications for Group 2 capsule biosynthesis. Biochem J 395: 427432.
  • Meredith TC, Mamat U, Kaczynski Z, Lindner B, Holst O & Woodard RW (2007) Modification of lipopolysaccharide with colanic acid (M-antigen) repeats in Escherichia coli. J Biol Chem 282: 77907798.
  • Mergulhao FJM, Summers DK & Monteiro GA (2005) Recombinant protein secretion in Escherichia coli. Biotechnol Adv 23: 177202.
  • Minshew BH, Jorgensen J, Swanstrum M, Grootes-Reuvecamp GA & Falkow S (1978) Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans. J Infect Dis 137: 648654.
  • Moe GR, Bhandari TS & Flitter BA (2009) Vaccines containing de-N-acetyl sialic acid elicit antibodies protective against Neisseria meningitidis groups B and C. J Immunol 182: 66106617.
  • Mohamad SAS, Azmi NA & Mohamed R (2012) Screening and identification of Pasteurella multocida capsular types among animal cases in Malaysia. 2012 IEEE Symposium on Humanities, Science and Engineering Research, pp. 737742. IEEE, DOI: 10.1109/SHUSER.2012.6268989.
  • Mordhorst IL, Claus H, Ewers C et al. (2009) O-acetyltransferase gene neuO is segregated according to phylogenetic background and contributes to environmental desiccation resistance in Escherichia coli K1. Environ Microbiol 11: 31543165.
  • Moxley RA & Francis DH (1986) Natural and experimental infection with an attaching and effacing strain of Escherichia coli in calves. Infect Immun 53: 339346.
  • Moxon ER & Kroll JS (1990) The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol 150: 6585.
  • Muñoz R, García E & López R (1998) Evidence for horizontal transfer from Streptococcus to Escherichia coli of the kfiD gene encoding the K5-specific UDP-glucose dehydrogenase. J Mol Evol 46: 432436.
  • Murkin AS, Chou WK, Wakarchuk WW & Tanner ME (2004) Identification and mechanism of a bacterial hydrolyzing UDP-N-acetylglucosamine 2-epimerase. Biochemistry 43: 1429014298.
  • Mushtaq N, Redpath MB, Luzio JP & Taylor PW (2004) Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype. Antimicrob Agents Chemother 48: 15031508.
  • Navia JL, Riesenfeld J, Vann WF, Lindahl U & Rodén L (1983) Assay of N-acetylheparosan deacetylase with a capsular polysaccharide from Escherichia coli K5 as substrate. Anal Biochem 135: 134140.
  • Ninomiya T, Sugiura N, Tawada A, Sugimoto K, Watanabe H & Kimata K (2002) Molecular cloning and characterization of chondroitin polymerase from Escherichia coli strain K4. J Biol Chem 277: 2156721575.
  • Nithya C, Begum MF & Pandian SK (2010) Marine bacterial isolates inhibit biofilm formation and disrupt mature biofilms of Pseudomonas aeruginosa PAO1. Appl Microbiol Biotechnol 88: 341358.
  • O'Flaherty S, Ross RP & Coffey A (2009) Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 33: 801819.
  • O'Hanlon KA, Catarame TMG, Duffy G, Blair IS & McDowell DA (2004) RAPID detection and quantification of E. coli O157/O26/O111 in minced beef by real-time PCR. J Appl Microbiol 96: 10131023.
  • Orskov F & Orskov I (1992) Escherichia coli serotyping and disease in man and animals. Can J Microbiol 38: 699704.
  • Orskov I, Orskov F, Jann B & Jann K (1977) Serology, chemistry, and genetics of O and K antigens of Escherichia coli. Bacteriol Rev 41: 667710.
  • Orskov F, Orskov I, Sutton A, Schneerson R, Lin W, Egan W, Hoff GE & Robbins JB (1979) Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide. J Exp Med 149: 669685.
  • Orskov I, Birch-Andersen A, Duguid JP, Stenderup J & Orskov F (1985) An adhesive protein capsule of Escherichia coli. Infect Immun 47: 191200.
  • Orth JD, Thiele I & Palsson BØ (2010) What is flux balance analysis? Nat Biotechnol 28: 245248.
  • Osawa T, Sugiura N, Shimada H, Hirooka R, Tsuji A, Shirakawa T, Fukuyama K, Kimura M, Kimata K & Kakuta Y (2009) Crystal structure of chondroitin polymerase from Escherichia coli K4. Biochem Biophys Res Commun 378: 1014.
  • van Oss CJ, Gillman CF & Neumann AW (1975) Phagocytic Engulfment and Cell Adhesiveness as Cellular Surface Phenomena. Vol. 2. Marcel Dekker, New York and Basel.
  • Ostblom A, Adlerberth I, Wold AE & Nowrouzian FL (2011) Pathogenicity island markers, virulence determinants malX and usp, and the capacity of Escherichia coli to persist in infants' commensal microbiotas. Appl Environ Microbiol 77: 23032308.
  • Otto NJ, Green DE, Masuko S, Mayer A, Tanner ME, Linhardt RJ & DeAngelis PL (2012) Structure/function analysis of Pasteurella multocida heparosan synthases: toward defining enzyme specificity and engineering novel catalysts. J Biol Chem 287: 72037212.
  • Pavelka MS, Wright LF & Silver RP (1991) Identification of two genes, kpsM and kpsT, in region 3 of the polysialic acid gene cluster of Escherichia coli K1. J Bacteriol 173: 46034610.
  • Pavelka MS, Hayes SF & Silver RP (1994) Characterization of KpsT, the ATP-binding component of the ABC-transporter involved with the export of capsular polysialic acid in Escherichia coli K1. J Biol Chem 269: 2014920158.
  • Pazzani C, Rosenow C, Boulnois GJ, Bronner D, Jann K & Roberts IS (1993) Molecular analysis of region 1 of the Escherichia coli K5 antigen gene cluster: a region encoding proteins involved in cell surface expression of capsular polysaccharide. J Bacteriol 175: 59785983.
  • Peterson PK, Wilkinson BJ, Kim Y, Schmeling D & Quie PG (1978) Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect Immun 19: 943949.
  • Petit C, Rigg GP, Pazzani C, Smith A, Sieberth V, Stevens M, Boulnois G, Jann K & Roberts IS (1995) Region 2 of the Escherichia coli K5 capsule gene cluster encoding proteins for the biosynthesis of the K5 polysaccharide. Mol Microbiol 17: 611620.
  • Pigeon RP & Silver RP (1994) Topological and mutational analysis of KpsM, the hydrophobic component of the ABC-transporter involved in the export of polysialic acid in Escherichia coli K1. Mol Microbiol 14: 871881.
  • Pluschke G, Mayden J, Achtman M & Levine RP (1983) Role of the capsule and the O antigen in resistance of O18:K1 Escherichia coli to complement-mediated killing. Infect Immun 42: 907913.
  • Poermadjaja B & Frost A (2000) Phagocytic uptake and killing of virulent and avirulent strains of Pasteurella multocida of capsular serotype A by chicken macrophages. Vet Microbiol 72: 163171.
  • Pon RA, Lussier M, Yang QL & Jennings HJ (1997) N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis. J Exp Med 185: 19291938.
  • Prasad SB, Jayaraman G & Ramachandran KB (2010) Hyaluronic acid production is enhanced by the additional co-expression of UDP-glucose pyrophosphorylase in Lactococcus lactis. Appl Microbiol Biotechnol 86: 273283.
  • Rafiq I, Parthasarathy H, Tremlett C, Freeman LJ & Mullin M (2011) Infective endocarditis caused by Moraxella nonliquefaciens in a percutaneous aortic valve replacement. Cardiovasc Revasc Med 12: 184186.
  • Rahn A, Beis K, Naismith JH & Whitfield C (2003) A novel outer membrane protein, Wzi, is involved in surface assembly of the Escherichia coli K30 Group 1 capsule. J Bacteriol 185: 58825890.
  • Raj A & van Oudenaarden A (2009) Single-molecule approaches to stochastic gene expression. Annu Rev Biophys 38: 255270.
  • Ralph AP & Carapetis JR (2013) Group a streptococcal diseases and their global burden. Curr Top Microbiol 368: 127.
  • Reid AN & Cuthbertson L (2012) Biosynthesis of capsular polysaccharides and exopolysaccharides. Bacterial Glycomics: Current Research, Technology and Applications (Reid CW, Twine SM & Reid AN, eds), pp. 2754. Caister Academic Press, Norfolk, UK.
  • Reizer J, Reizer A & Saier MH (1992) A new subfamily of bacterial ABC-type transport systems catalyzing export of drugs and carbohydrates. Protein Sci 1: 13261332.
  • Restaino OF, Cimini D, De Rosa M, Catapano A & Schiraldi C (2011) High cell density cultivation of Escherichia coli K4 in a microfiltration bioreactor: a step towards improvement of chondroitin precursor production. Microb Cell Fact 10: 110.
  • Restaino OF, Di Lauro I, Cimini D, Carlino E, De Rosa M & Schiraldi C (2012) Monosaccharide precursors for boosting chondroitin-like capsular polysaccharide production. Appl Microbiol Biotechnol 97: 16991709.
  • Rice JA, Carrasco-Medina L, Hodgins DC & Shewen PE (2007) Mannheimia haemolytica and bovine respiratory disease. Anim Health Res Rev 8: 117128.
  • Rigg GP, Barrett B & Roberts IS (1998) The localization of KpsC, S and T, and KfiA, C and D proteins involved in the biosynthesis of the Escherichia coli K5 capsular polysaccharide: evidence for a membrane-bound complex. Microbiology 144(Pt 10): 29052914.
  • Rimler RB & Rhoades KR (1987) Serogroup F, a new capsule serogroup of Pasteurella multocida. J Clin Microbiol 25: 615618.
  • Rimler RB, Register KB, Magyar T & Ackermann MR (1995) Influence of chondroitinase on indirect hemagglutination titers and phagocytosis of Pasteurella multocida serogroups A, D and F. Vet Microbiol 47: 287294.
  • Robbins JB, McCracken GH, Gotschlich EC, Orskov F, Orskov I & Hanson LA (1974) Escherichia coli K1 capsular polysaccharide associated with neonatal meningitis. N Engl J Med 290: 12161220.
  • Roberts IS (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu Rev Microbiol 50: 285315.
  • Roberts IS, Mountford R, High N, Bitter-Suermann D, Jann K, Timmis K & Boulnois G (1986) Molecular cloning and analysis of genes for production of K5, K7, K12, and K92 capsular polysaccharides in Escherichia coli. J Bacteriol 168: 12281233.
  • Rodriguez ML, Jann B & Jann K (1988) Structure and serological characteristics of the capsular K4 antigen of Escherichia coli O5:K4:H4, a fructose-containing polysaccharide with a chondroitin backbone. Eur J Biochem 177: 117124.
  • Rosenow C, Roberts IS & Jann K (1995a) Isolation from recombinant Escherichia coli and characterization of CMP-Kdo synthetase, involved in the expression of the capsular K5 polysaccharide (K-CKS). FEMS Microbiol Lett 125: 159164.
  • Rosenow C, Esumeh F, Roberts IS & Jann K (1995b) Characterization and localization of the KpsE protein of Escherichia coli K5, which is involved in polysaccharide export. J Bacteriol 177: 11371143.
  • Rowe S, Hodson N, Griffiths G & Roberts IS (2000) Regulation of the Escherichia coli K5 capsule gene cluster: evidence for the roles of H-NS, BipA, and integration host factor in regulation of Group 2 capsule gene clusters in pathogenic E. coli. J Bacteriol 182: 27412745.
  • Rutishauser U (2008) Polysialic acid in the plasticity of the developing and adult vertebrate nervous system. Nat Rev Neurosci 9: 2635.
  • Rutishauser U, Watanabe M, Silver J, Troy FA & Vimr ER (1985) Specific alteration of NCAM-mediated cell adhesion by an endoneuraminidase. J Cell Biol 101: 18421849.
  • Sandberg T, Kaijser B, Lidin-Janson G, Lincoln K, Orskov F, Orskov I, Stokland E & Svanborg-Edén C (1988) Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection. J Clin Microbiol 26: 14711476.
  • Sarff LD, McCracken GH, Schiffer MS, Glode MP, Robbins JB, Orskov I & Orskov F (1975) Epidemiology of Escherichia coli K1 in healthy and diseased newborns. Lancet 1: 10991104.
  • Sawata A & Kume K (1983) Relationships between virulence and morphological or serological properties of variants dissociated from serotype 1 Haemophilus paragallinarum strains. J Clin Microbiol 18: 4955.
  • Schiraldi C, Cimini D & De Rosa M (2010) Production of chondroitin sulfate and chondroitin. Appl Microbiol Biotechnol 87: 12091220.
  • Schiraldi C, Carcarino IL, Alfano A, Restaino OF, Panariello A & De Rosa M (2011) Purification of chondroitin precursor from Escherichia coli K4 fermentation broth using membrane processing. Biotechnol J 6: 410419.
  • Schiraldi C, Alfano A, Cimini D, De Rosa M, Panariello A & Restaino Odile F (2012) Application of a 22L scale membrane bioreactor and cross-flow ultrafiltration to obtain purified chondroitin. Biotechnol Prog 28: 10121018.
  • Scholl D, Rogers S, Adhya S & Merril CR (2001) Bacteriophage K1-5 encodes two different tail fiber proteins, allowing it to infect and replicate on both K1 and K5 strains of Escherichia coli. J Virol 75: 25092515.
  • Scholl D, Adhya S & Merril C (2005) Escherichia coli K1's capsule is a barrier to bacteriophage T7. Appl Environ Microbiol 71: 48724874.
  • Schrager HM, Rheinwald JG & Wessels MR (1996) Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest 98: 19541958.
  • Schroeder B, Duncker S, Barth S, Bauerfeind R, Gruber AD, Deppenmeier S & Breves G (2006) Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. Dig Dis Sci 51: 724731.
  • Schulz EC, Bergfeld AK, Ficner R & Mühlenhoff M (2011) Crystal structure analysis of the polysialic acid specific O-acetyltransferase NeuO. PLoS ONE 6: e17403.
  • Shen Y, Liu J, Estiu G, Isin B, Ahn YY, Lee DS, Barabási AL, Kapatral V, Wiest O & Oltvai ZN (2010) Blueprint for antimicrobial hit discovery targeting metabolic networks. P Natl Acad Sci USA 107: 10821087.
  • Shuren J (2006) Food additives permitted for direct addition to food for human consumption; bacteriophage preparation. Fed Reg 71: 4772947732.
  • Sieberth V, Rigg GP, Roberts IS & Jann K (1995) Expression and characterization of UDPGlc dehydrogenase (KfiD), which is encoded in the type-specific region 2 of the Escherichia coli K5 capsule genes. J Bacteriol 177: 45624565.
  • Silver RP, Finn CW, Vann WF, Aaronson W, Schneerson R, Kretschmer PJ & Garon CF (1981) Molecular cloning of the K1 capsular polysaccharide genes of E. coli. Nature 289: 696698.
  • Silver RP, Aaronson W & Vann WF (1988) The K1 capsular polysaccharide of Escherichia coli. Rev Infect Dis 10(Suppl 2): S282S286.
  • Simonen M & Palva I (1993) Protein secretion in Bacillus species. Microbiol Rev 57: 109137.
  • Simpson DA, Hammarton TC & Roberts IS (1996) Transcriptional organization and regulation of expression of region 1 of the Escherichia coli K5 capsule gene cluster. J Bacteriol 178: 64666474.
  • Smith AN, Boulnois GJ & Roberts IS (1990) Molecular analysis of the Escherichia coli K5 kps locus: identification and characterization of an inner-membrane capsular polysaccharide transport system. Mol Microbiol 4: 18631869.
  • Spinosa MR, Progida C, Talà A, Cogli L, Alifano P & Bucci C (2007) The Neisseria meningitidis capsule is important for intracellular survival in human cells. Infect Immun 75: 35943603.
  • Steen JA, Steen JA, Harrison P, Seemann T, Wilkie I, Harper M, Adler B & Boyce JD (2010) Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors. PLoS Pathog 6: e1000750.
  • Steenbergen SM & Vimr ER (2008) Biosynthesis of the Escherichia coli K1 Group 2 polysialic acid capsule occurs within a protected cytoplasmic compartment. Mol Microbiol 68: 12521267.
  • Stevens P, Huang SN, Welch WD & Young LS (1978) Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity. J Immunol 121: 21742180.
  • Stevens MP, Clarke BR & Roberts IS (1997) Regulation of the Escherichia coli K5 capsule gene cluster by transcription antitermination. Mol Microbiol 24: 10011012.
  • Stordeur P, China B, Charlier G, Roels S & Mainil J (2000) Clinical signs, reproduction of attaching/effacing lesions, and enterocyte invasion after oral inoculation of an O118 enterohaemorrhagic Escherichia coli in neonatal calves. Microbes Infect 2: 1724.
  • Storm DW, Koff SA, Horvath DJ, Li B & Justice SS (2011) In vitro analysis of the bactericidal activity of Escherichia coli Nissle 1917 against pediatric uropathogens. J Urol 186: 16781683.
  • Stummeyer K, Dickmanns A, Mühlenhoff M, Gerardy-Schahn R & Ficner R (2004) Crystal structure of the polysialic acid–degrading endosialidase of bacteriophage K1F. Nat Struct Mol Biol 12: 9096.
  • Sugahara K & Mikami T (2007) Chondroitin/dermatan sulfate in the central nervous system. Curr Opin Struct Biol 17: 536545.
  • Sulakvelidze A, Alavidze Z & Morris JG (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45: 649659.
  • Sun J, Gunzer F, Westendorf AM, Buer J, Scharfe M, Jarek M, Gössling F, Blöcker H & Zeng AP (2005) Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. J Biotechnol 117: 147161.
  • Sun W, Du L & Li M (2010) Aptamer-based carbohydrate recognition. Curr Pharm Des 16: 22692278.
  • Surana NK & Kasper DL (2012) The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol Rev 245: 1326.
  • Tang L, Liu Y, Ali MM, Kang DK, Zhao W & Li J (2012) Colorimetric and ultrasensitive bioassay based on a dual-amplification system using aptamer and DNAzyme. Anal Chem 84: 47114717.
  • Thelin MA, Bartolini B, Axelsson J, Gustafsson R, Tykesson E, Pera E, Oldberg A, Maccarana M & Malmstrom A (2013) Biological functions of iduronic acid in chondroitin/dermatan sulfate. FEBS J 280: 24312446.
  • Thompson JE, Pourhossein M, Waterhouse A, Hudson T, Goldrick M, Derrick JP & Roberts IS (2010) The K5 lyase KflA combines a viral tail spike structure with a bacterial polysaccharide lyase mechanism. J Biol Chem 285: 2396323969.
  • Tian X, Azpurua J, Hine C, Vaidya A, Myakishev-Rempel M, Ablaeva J, Mao Z, Nevo E, Gorbunova V & Seluanov A (2013) High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature 499: 346349.
  • Tjalsma H, Antelmann H, Jongbloed JD et al. (2004) Proteomics of protein secretion by Bacillus subtilis: separating the “secrets” of the secretome. Microbiol Mol Biol Rev 68: 207233.
  • Tombelli S, Minunni M & Mascini M (2005) Analytical applications of aptamers. Biosens Bioelectron 20: 24242434.
  • Townsend KM, Boyce JD, Chung JY, Frost AJ & Adler B (2001) Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system. J Clin Microbiol 39: 924929.
  • Trilli A, Busiello I, Daly S & Bagatin F (2012) Biotechnological production of chondroitin. WIPO Patent Number 2012004063.
  • Troy FA (1992) Polysialylation: from bacteria to brains. Glycobiology 2: 523.
  • Tzeng Y, Datta AK, Strole CA, Lobritz MA, Carlson RW & Stephens DS (2005) Translocation and surface expression of lipidated serogroup B capsular polysaccharide in Neisseria meningitidis. Infect Immun 73: 14911505.
  • Valle J, Da Re S, Henry N, Fontaine T, Balestrino D, Latour-Lambert P & Ghigo JM (2006) Broad-spectrum biofilm inhibition by a secreted bacterial polysaccharide. P Natl Acad Sci USA 103: 1255812563.
  • Vann WF, Schmidt MA, Jann B & Jann K (1981) The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur J Biochem 116: 359364.
  • Vann WF, Daines DA, Murkin AS, Tanner ME, Chaffin DO, Rubens CE, Vionnet J & Silver RP (2004) The NeuC protein of Escherichia coli K1 is a UDP N-acetylglucosamine 2-epimerase. J Bacteriol 186: 706712.
  • Varki A (2006) Nothing in glycobiology makes sense, except in the light of evolution. Cell 126: 841845.
  • Veasy LG, Tani LY, Daly JA, Korgenski K, Miner L, Bale J, Kaplan EL, Musser JM & Hill HR (2004) Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113: e168e172.
  • Vimr ER & Steenbergen SM (2006) Mobile contingency locus controlling Escherichia coli K1 polysialic acid capsule acetylation. Mol Microbiol 60: 828837.
  • Vimr ER, Aaronson W & Silver RP (1989) Genetic analysis of chromosomal mutations in the polysialic acid gene cluster of Escherichia coli K1. J Bacteriol 171: 11061117.
  • Vinkenborg JL, Karnowski N & Famulok M (2011) Aptamers for allosteric regulation. Nat Chem Biol 7: 519527.
  • Vintiñi E, Villena J, Alvarez S & Medina M (2010) Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice. Clin Exp Immunol 159: 351362.
  • Voigt CA (2006) Genetic parts to program bacteria. Curr Opin Biotechnol 17: 548557.
  • Vollmer W (2008) Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol Rev 32: 287306.
  • Volpi N (2007) Mass spectrometry characterization of Escherichia coli K4 oligosaccharides from 2-mers to more than 20-mers. Rapid Commun Mass Spectrom 21: 34593466.
  • Volpi N, Zhang Z & Linhardt RJ (2008) Mass spectrometry for the characterization of unsulfated chondroitin oligosaccharides from 2-mers to 16-mers. Comparison with hyaluronic acid oligomers. Rapid Commun Mass Spectrom 22: 35263530.
  • Wang X, Preston JF & Romeo T (2004) The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol 186: 27242734.
  • Wang X, Dubey AK, Suzuki K, Baker CS, Babitzke P & Romeo T (2005) CsrA post-transcriptionally represses pgaABCD, responsible for synthesis of a biofilm polysaccharide adhesin of Escherichia coli. Mol Microbiol 56: 16481663.
  • Wang Z, Ly M, Zhang F, Zhong W, Suen A, Hickey AM, Dordick JS & Linhardt RJ (2010) E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol Bioeng 107: 964973.
  • Wang Z, Yang B, Zhang Z, Ly M, Takieddin M, Mousa S, Liu J, Dordick JS & Linhardt RJ (2011) Control of the heparosan N-deacetylation leads to an improved bioengineered heparin. Appl Microbiol Biotechnol 91: 9199.
  • Ward PN, Field TR, Ditcham WG, Maguin E & Leigh JA (2001) Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis. Infect Immun 69: 392399.
  • Watt JM, Wade MM, Holman SC, Wilson WW, Keil DE, Pruett SB, Jacques M & Champlin FR (2003) Influence of serotype A capsulation on cell surface physiologic factors in Pasteurella multocida. Colloids Surf B 28: 227238.
  • Wei Z, Fu Q, Chen Y, Cong P, Xiao S, Mo D, He Z & Liu X (2012) The capsule of Streptococcus equi ssp. zooepidemicus is a target for attenuation in vaccine development. Vaccine 30: 46704675.
  • Weintraub A (2003) Immunology of bacterial polysaccharide antigens. Carbohydr Res 338: 25392547.
  • Wells CL, Maddaus MA & Simmons RL (1988) Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 10: 958979.
  • Wessels MR, Rubens CE, Benedí VJ & Kasper DL (1989) Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. P Natl Acad Sci USA 86: 89838987.
  • Wessels MR, Moses AE, Goldberg JB & DiCesare TJ (1991) Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. P Natl Acad Sci USA 88: 83178321.
  • Whitfield C (2006) Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem 75: 3968.
  • Whitfield C & Roberts IS (1999) Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol 31: 13071319.
  • Wibawan IW, Pasaribu FH, Utama IH, Abdulmawjood A & Lämmler C (1999) The role of hyaluronic acid capsular material of Streptococcus equi subsp. zooepidemicus in mediating adherence to HeLa cells and in resisting phagocytosis. Res Vet Sci 67: 131135.
  • Widner B, Behr R, Von Dollen S, Tang M, Heu T, Sloma A, Sternberg D, DeAngelis PL, Weigel PH & Brown S (2005) Hyaluronic acid production in Bacillus subtilis. Appl Environ Microbiol 71: 37473752.
  • Wildi LM, Raynauld JP, Martel-Pelletier J, Beaulieu A, Bessette L, Morin F, Abram F, Dorais M & Pelletier JP (2011) Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 70: 982989.
  • Wiles TJ, Kulesus RR & Mulvey MA (2008) Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol Pathol 85: 1119.
  • Willis LM, Stupak J, Richards MR, Lowary TL, Li J & Whitfield C (2013) Conserved glycolipid termini in capsular polysaccharides synthesized by ATP-binding cassette transporter-dependent pathways in Gram-negative pathogens. P Natl Acad Sci USA 110: 78687873.
  • Winkelstein JA (1981) The role of complement in the host's defense against Streptococcus pneumoniae. Rev Infect Dis 3: 289298.
  • Wu JR, Chen PY, Shien JH, Shyu CL, Shieh HK, Chang F & Chang PC (2010) Analysis of the biosynthesis genes and chemical components of the capsule of Avibacterium paragallinarum. Vet Microbiol 145: 9099.
  • Wu Q, Yang A, Zou W, Duan Z, Liu J, Chen J & Liu L (2013) Transcriptional engineering of Escherichia coli K4 for fructosylated chondroitin production. Biotechnol Prog 29: 11401149.
  • Wunder DE, Aaronson W, Hayes SF, Bliss JM & Silver RP (1994) Nucleotide sequence and mutational analysis of the gene encoding KpsD, a periplasmic protein involved in transport of polysialic acid in Escherichia coli K1. J Bacteriol 176: 40254033.
  • Xue P, Corbett D, Goldrick M, Naylor C & Roberts IS (2009) Regulation of expression of the region 3 promoter of the Escherichia coli K5 capsule gene cluster involves H-NS, SlyA, and a large 5′ untranslated region. J Bacteriol 191: 18381846.
  • Yi W, Zhu L, Guo H, Mei L, Li J & Wang PG (2006) Formation of a new O-polysaccharide in Escherichia coli O86 via disruption of a glycosyltransferase gene involved in O-unit assembly. Carbohydr Res 341: 22542260.
  • Yu H & Stephanopoulos G (2008) Metabolic engineering of Escherichia coli for biosynthesis of hyaluronic acid. Metab Eng 10: 2432.
  • Yu H, Tyo K, Alper H, Klein-Marcuschamer D & Stephanopoulos G (2008) A high-throughput screen for hyaluronic acid accumulation in recombinant Escherichia coli transformed by libraries of engineered sigma factors. Biotechnol Bioeng 101: 788796.
  • Zanfardino A, Restaino OF, Notomista E, Cimini D, Schiraldi C, De Rosa M, De Felice M & Varcamonti M (2010) Isolation of an Escherichia coli K4 kfoC mutant over-producing capsular chondroitin. Microb Cell Fact 9: 18.
  • Zehnder JL & Galli SJ (1999) Mast-cell heparin demystified. Nature 400: 714715.
  • Zhang C, Liu L, Teng L, Chen J, Liu J, Li J, Du G & Chen J (2012) Metabolic engineering of Escherichia coli BL21 for biosynthesis of heparosan, a bioengineered heparin precursor. Metab Eng 14: 521527.
  • Zhao Q, Sun Y, Zhang X, Kong Y, Xie Z, Zhu Y, Zhou E & Jiang S (2010) Evaluation of two experimental infection models for Avibacterium paragallinarum. Vet Microbiol 141: 6872.
  • Zhu H, Wang Q, Wen L, Xu J, Shao Z, Chen M, Chen M, Reeves PR, Cao B & Wang L (2012) Development of a multiplex PCR assay for detection and genogrouping of Neisseria meningitidis. J Clin Microbiol 50: 4651.
  • Zingler G, Schmidt G, Orskov I, Orskov F, Falkenhagen U & Naumann G (1990) K-antigen identification, hemolysin production, and hemagglutination types of Escherichia coli O6 strains isolated from patients with urinary tract infections. Zentralbl Bakteriol 274: 372381.
  • Zogaj X, Nimtz M, Rohde M, Bokranz W & Römling U (2001) The multicellular morphotypes of Salmonella typhimurium and Escherichia coli produce cellulose as the second component of the extracellular matrix. Mol Microbiol 39: 14521463.